News

Recently, Autobio's wholly-owned subsidiary, Autobio Laboratory Instruments (Zhengzhou) Co., Ltd., was granted an international invention patent (EP3916077) by the European Patent Office for its 'Fully Automated Microbial Identification and Drug Sensitivity Analysis System'. This achievement is not only a solid step in the protection of international intellectual property rights, but also highlights the company's innovative capability in the field of microbiological testing.

In recent years, the widespread use of antibacterial drugs has led to a rapid increase in drug-resistant strains, causing great difficulties in clinical treatment. Due to the irrational use of antibiotics, treatment failure rates and side effects have increased dramatically. Therefore, drug susceptibility testing is becoming increasingly important in the prevention and treatment of infectious diseases.

AutoMic-i600 is a fully automated and intelligent instrument that has been developed by Autobio over the years. Its unique functions such as automatic sample addition, intelligent identification, automatic incubation and interpretation precisely meet the current needs and pain points in the clinical field, and it is capable of rapid and accurate microbial identification and in vitro drug susceptibility testing, and its performance reaches the domestic advanced level. It has the following features

Automation: automation and integration of sample addition, incubation and detection;

Intelligent: colorimetric and turbidimetric joint determination, 4-wavelength simultaneous detection, timed uninterrupted automatic interpretation, introduction of AI intelligent algorithm model, more accurate detection results;

High throughput: with 64-card high throughput incubation chamber, it meets the needs of users at all levels of detection;

Informatisation: reagent information and plate information can be automatically identified; it can be seamlessly connected to microbiology laboratory management system and LIS system.

The introduction and application of AutoMic-i600, a fully automatic microbiological identification drug susceptibility analyser, has opened up the last and most critical link of clinical microbiological testing, further enriched the Company's microbiological testing product line, and the products are exported to Europe, South America, Africa, the Middle East, Southeast Asia and other countries and regions. The acquisition of this invention patent lays a solid foundation for the global promotion of the product.